Top Glucose Monitor Brands: A Sweet Guide to Health

Monitoring blood glucose levels is a crucial aspect of managing diabetes, and choosing the right glucose monitor can make a significant difference in your daily life. With a variety of brands offering unique features and technologies, finding the right one can seem daunting. It's essential to consider factors such as accuracy, ease of use, and additional features like mobile app integration when selecting a glucose monitor. For an in-depth look at some of the best brands available and how they compare, take a look at the detailed list below.

Illustration of glucose monitor

Best brands of glucose monitor in 2025

Dexcom

Dexcom is a leading producer of glucose monitoring devices, dominating the market with 44.27% of patents for continuous glucose monitoring systems. Since 1999, Dexcom has been innovating glucose biosensing technologies, setting the standard for real-time glucose monitoring. Their flagship product, the Dexcom G7, is recognized as the most accurate CGM available, offering real-time glucose feedback and numerous partner connections. Dexcom anticipates significant revenue growth, with an expected total revenue of $4.15 billion to $4.35 billion in 2024, representing a 16% to 21% organic growth over 2023. The company is also set to launch Stelo, a new glucose sensor for type 2 diabetes patients not using insulin, in summer 2024.

Abbott

Abbott's Freestyle Libre has established itself as one of the most successful medical technology products in history, with $4.3 billion in sales in 2022, a 22% increase year over year. The company aims to reach $10 billion in sales by 2028, requiring a compound annual growth rate of 15%. With over 5 million users worldwide, including 2 million in the United States, Freestyle Libre has become a mainstream product due to its pain-free, highly accurate, and cost-effective design. The latest Freestyle Libre 3 Plus sensor offers an extended 15-day wear time and integration with insulin pumps, further enhancing its market appeal. Medicare coverage for these devices has also expanded, including those who only take basal insulin. For more information, visit Abbott's official Freestyle Libre website.

Medtronic

Medtronic is a significant player in the glucose monitoring market, known for its advanced devices such as the MiniMed 780G insulin pump and the Guardian 4 sensor, which were recently approved by the FDA. The company's U.S. diabetes business, although declining since 2019, still accounts for about 38% of Medtronic's total diabetes sales, with insulin pumps and continuous glucose monitors making up 63% of these sales. Medtronic holds a notable 10.15% share of patents for continuous glucose monitoring devices, indicating its strong innovation focus. Despite regulatory challenges, Medtronic remains a key competitor in the market, projected to grow significantly, with the global glucose monitoring devices market expected to reach $38.9 billion by 2033. The company's products are integral to the holistic management of diabetes, incorporating advanced technologies like real-time glucose monitoring and predictive analytics.

Accu-Chek

Roche's Accu-Chek brand is a leading producer of glucose monitoring devices, known for its innovative and accurate products. The Accu-Chek Inform II system, for instance, delivers results in just 5 seconds and has been a top revenue generator, maintaining its largest revenue share in the market since 2018. The brand's newest entry, the Accu-Chek Smartguide CGM, features AI-based predictive algorithms to enhance glycemic control and has recently received a CE mark for distribution in selected European markets. The global point-of-care glucose testing market, dominated by Accu-Chek products, is expected to grow at a CAGR of 4.1% from 2023 to 2030, reaching USD 4.51 billion by 2030. Accu-Chek devices are favored for their ease of use and efficient data transfer, making them a preferred choice in medical settings.

OneTouch

The OneTouch brand by LifeScan is a leading provider of blood glucose monitoring devices, recognized for its excellence in consumer experience and affordability. The OneTouch Verio Flex meter, for instance, was rated the Best Standard Glucose Meter of 2022 by Forbes Health due to its low price, affordable test strips, color range indicator, and compact design. This meter, equipped with ColorSure(r) technology, helps users easily track and manage their blood sugar levels, especially when used in conjunction with the OneTouch Reveal(r) mobile app. Over 20 million people worldwide rely on OneTouch products, highlighting the brand's trust and simplicity in diabetes management. LifeScan's commitment to innovation has been evident for over 40 years, advocating for deeper care management strategies among healthcare providers and payers.

Contour

The Contour brand, operated by Ascensia Diabetes Care, is a leading producer of blood glucose monitoring devices, known for its high-quality and user-friendly products. The Contour blood glucose monitoring system is set to grow with a CAGR of 5.5% from 2019-2025, indicating strong market performance. In 2023, North America, where Ascensia has a significant presence, dominated the blood glucose monitoring devices market with a share of 38.44%. Ascensia's Contour products, such as the Contour NEXT GEN blood glucose meters, are popular for their accuracy and convenience, requiring only a 0.6 microliter blood sample for testing. The brand's commitment to innovation and patient care has made it a trusted name in the diabetes management sector.

Eversense

Eversense, developed by Senseonics, stands out as a leading brand in the continuous glucose monitoring (CGM) market, offering innovative and reliable solutions for diabetes management. The Eversense CGM system, particularly the Eversense 365, provides real-time glucose readings for up to a year, with a high wear-time of 83.6% and excellent glycemic control, as evidenced by 62.3% time in range between 70 to 180 mg/dL. This system is notable for its minimal hypoglycemia rates, with users spending only 1.7% of nighttime in hypoglycemia (<54 mg/dL). The sensor is implanted subcutaneously and requires calibration twice a day, ensuring accurate and continuous monitoring. With its advanced technology and user-friendly design, Eversense has become a valuable tool for individuals managing diabetes.

Bayer

Bayer is a leading producer in the point-of-care glucose testing market, with its CONTOUR blood glucose monitoring system expected to grow at a CAGR of 5.5% from 2019 to 2025. The company's products are part of a market valued at USD 3,670.9 million in 2024, projected to reach USD 5,455.3 million by 2033. Bayer's devices are popular due to their accuracy and user-friendly design, contributing to the company's significant market share. The North American region, where Bayer has a strong presence, leads the market with a high demand for innovative diagnostic techniques. Bayer's products, such as the CONTOUR system, are integral to the growing global blood glucose monitoring devices market.

iHealth

The iHealth brand is renowned for its innovative and accurate glucose monitoring solutions, such as the iHealth Gluco+ Wireless Smart Glucose Meter, which has obtained FDA 510K clearance and CE certification, ensuring strict adherence to global standards for accuracy and reliability. This device allows users to store, track, and share blood glucose readings, set personalized target ranges, and receive reminders, all through the iGluco app. With a minimal blood sample of just 0.7 microliters, users can get accurate results in 5 seconds. The market for self-monitoring blood glucose devices, which includes iHealth products, is expected to grow significantly, with the U.S. market projected to reach USD 7,138 million by 2032, growing at a CAGR of 6.5% from 2024 to 2032.

AgaMatrix

AgaMatrix, renowned for its innovative WaveSense technology, stands as a leading producer of glucose monitors, having manufactured over 8 million devices and three billion sensors. Their products, such as the WaveSense Presto and the Jazz Wireless 2, offer nearly 99% accurate readings and feature advanced connectivity, allowing users to easily capture, analyze, and share glucose results. AgaMatrix has developed the first FDA-cleared blood glucose meter/app for iPhone and collaborates with major retailers and pharmaceutical companies. Their commitment to continuous innovation in biosensor technology and blood glucose monitoring has been recognized by publications like the New York Times and Fast Company. With a compact, modern design and no-code technology, AgaMatrix products simplify diabetes management. For more information, visit their official website.